Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tetanus toxoid + diphtheria toxoid (Bio Farma)
- Development stage
- Approved
- Lead developer
- Bio Farma
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Adsorbed Td Vaccine from Bio Farma is a booster vaccine containing tetanus toxoid and diphtheria toxoid as active ingredients. Developed and manufactured by Bio Farma, an Indonesian state-owned pharmaceutical company, this vaccine is indicated for booster immunization against tetanus and diphtheria infections in individuals aged 7 years and older. As a toxoid-based biologic, it works by inducing active immunity through the production of antibodies against the toxins produced by *Clostridium tetani* and *Corynebacterium diphtheriae*. The formulation contains a reduced dose of diphtheria toxoid compared to pediatric DTP vaccines, making it suitable for older children and adults to minimize local reactions. It is typically administered as a single 0.5 ml intramuscular injection.
- Brand names
- Adsorbed Td Vaccine
- Other names
- Td vaccineTetanus-Diphtheria (Td) vaccineTd
02
Targets
TT (Tetanus toxoid)
Beyond the preview
Go deeper on tetanus toxoid + diphtheria toxoid (Bio Farma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tetanus toxoid + diphtheria toxoid (Bio Farma).